Post-MPN AML: Real-World Outcomes and Ongoing Challenges

Post-MPN AML: Real-World Outcomes and Ongoing Challenges

Have newer therapies improved outcomes for patients with acute myeloid leukemia after myeloproliferative neoplasms, or post-MPN AML? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is joined by Dr. Jan Philipp Bewersdorf and Dr. Anand Patel to discuss an article in Cancer evaluating real-world outcomes among patients with post-MPN AML in the United States. Their conversation explores survival trends in the era of novel therapies, barriers to allogeneic hematopoietic cell transplantation, and future directions for improving outcomes in this rare, high-risk disease.

Read the accompanying article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70415

Follow Cancer on social media: x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals

Original music by J. Gilman.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(26)

Annual Report to the Nation: Cancer Trends and Progress Against Lung Cancer

Annual Report to the Nation: Cancer Trends and Progress Against Lung Cancer

What do the latest data tell us about cancer in the United States, and what’s behind the substantial progress against lung cancer over the past two decades? In this episode of CancerSpeak, Jane Henley...

22 Sep 24min

Advancing Pediatric and AYA Oncology: Perspectives from the Editors

Advancing Pediatric and AYA Oncology: Perspectives from the Editors

Where is pediatric and adolescent and young adult (AYA) oncology headed—and what research is needed to move the field forward? In this episode of CancerSpeak, Dr. Nirali Shah, Editor-in-Chief of Pedia...

9 Sep 21min

Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

What are the latest recommendations for frontline acute lymphoblastic leukemia (ALL) treatment? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is j...

11 Aug 10min

Top Advances of the Year: Palliative and Supportive Care in Oncology

Top Advances of the Year: Palliative and Supportive Care in Oncology

Palliative and supportive care helps reduce suffering, manage symptoms, and improve quality of life for people living with cancer, yet many patients still face barriers to accessing these services. Re...

13 Jul 21min

Antibody–Drug Conjugates: Clinical Perspectives from Europe

Antibody–Drug Conjugates: Clinical Perspectives from Europe

Dr. Daniel Morgensztern, Section Editor of Chest and Lung Disease for the journal Cancer, is joined by Dr. Emiliano Calvo and Dr. André Mansinho to discuss a new supplement in Cancer focused on recent...

2 Jun 22min

A New Home for Pediatric and AYA Oncology Research

A New Home for Pediatric and AYA Oncology Research

In this episode of CancerSpeak, Dr. Nirali Shah is joined by Dr. William Dahut, Chief Scientific Officer of the American Cancer Society, and Dr. Suresh Ramalingam, Editor-in-Chief of Cancer, to discus...

19 Mai 13min

Low-Grade Gliomas: Evolving Approaches to Care

Low-Grade Gliomas: Evolving Approaches to Care

Dr. Priya Kumthekar, Neuro-Oncology Section Editor for CANCER, and Dr. Helen Shih, Radiation Oncology Section Editor for CANCER, discuss the current treatment landscape for low-grade gliomas with a fo...

7 Jan 15min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
jss
liberal-halvtime
forskningno
rekommandert
sinnsyn
rss-paradigmepodden
smart-forklart
fjellsportpodden
rss-nysgjerrige-norge
villmarksliv
nordnorsk-historie
grunnstoffene
rss-rekommandert
vett-og-vitenskap-med-gaute-einevoll
rss-overskuddsliv
nevropodden
tidlose-historier